Back

Biological Psychiatry

36 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
1H-MRS metabolites in antipsychotic-responsive versus non-responsive psychosis: a meta- and mega-analysis.
2025-12-11 psychiatry and clinical psychology 10.64898/2025.12.10.25341974
#1 (14.0%)
Show abstract

Understanding the mechanisms underlying the response to antipsychotic medications is critical for refining targets for new interventions and predicting clinical outcomes. This study presents a mega-analysis of individual participant data (N = 1,189) from 18 {superscript 1}H-MRS datasets to examine differences in neurometabolites in antipsychotic non-responsive compared to antipsychotic-responsive psychosis, accompanied by complementary meta-analyses across the wider published literature (23 stud...

2
Grey Matter Iron and Neuromelanin in Psychosis: A Systematic Review and Meta-Analysis of MRI Studies
2026-01-17 psychiatry and clinical psychology 10.64898/2026.01.15.26344182
#1 (10.2%)
Show abstract

ObjectiveThe pathophysiology of psychosis remains unclear. Preclinical, postmortem, and imaging evidence implicates iron and neuromelanin, but the consistency and magnitude of effects are uncertain. We aimed to characterise brain iron and neuromelanin alterations in psychosis through a systematic review and meta-analysis of iron-sensitive MRI and neuromelanin-sensitive MRI (NM-MRI) studies. MethodsWe searched EMBASE, PubMed, and PsycINFO from inception to October 31, 2025, for case-control stud...

3
Data-driven profiles of psychosis stages reveal distinct and overlapping clinical, cognitive, and neuroanatomical phenotypes
2026-03-05 psychiatry and clinical psychology 10.64898/2026.03.04.26347618
#1 (8.8%)
Show abstract

Psychotic disorders are increasingly recognized as the extreme end of a progressive psychopathology continuum, with less advanced stages including the asymptomatic familial high-risk state (FHR), the help-seeking clinical high-risk state (CHR), and first episode psychosis (FEP). However, we lack a comprehensive study of clinical, cognitive, functional, and neuroanatomical markers across all three early stages of psychosis, limiting our understanding of how the multimodal phenotypes which define ...

4
GAMBIT: A Digital Tool to Train Distinct Inhibitory Control Mechanisms
2026-03-06 psychiatry and clinical psychology 10.64898/2026.03.05.26347639
#1 (8.7%)
Show abstract

Deficits in inhibitory control are common across a wide range of psychiatric disorders and are closely linked to symptom severity, including emotional dysregulation, anxiety, substance misuse, and self-harm, making them an appealing target for intervention. Cognitive training offers a low-cost, scalable, and non-invasive strategy to strengthen inhibitory control; however, most existing paradigms target only a single facet of inhibition and rarely account for environmental influences, such as aff...

5
Plasma Lipid Alterations Track Multidimensional Psychosis Severity Across Diagnostic Boundaries
2026-02-26 psychiatry and clinical psychology 10.64898/2026.02.24.26346956
Top 0.2% (7.8%)
Show abstract

BackgroundLipidomic alterations have been reported across schizophrenia (SCZ) and bipolar disorder (BD), but findings are heterogeneous and often overlap across diagnoses, limiting diagnostic specificity. Associations between lipid profiles and illness severity have also been inconsistent when assessed using single symptom scales, raising the possibility that unidimensional measures fail to capture biologically relevant variation. Whether plasma lipidomic alterations relate to multidimensional p...

6
Functional Genomic Analyses Reveal transfer RNA Modification Enzymes as Risk Genes for Bipolar I Disorder and Schizophrenia
2026-01-27 psychiatry and clinical psychology 10.64898/2026.01.26.26344826
Top 0.2% (7.8%)
Show abstract

Enzyme-mediated RNA modifications provide a versatile and dynamic regulatory layer that fine-tunes gene expression programs throughout brain development and in mature neural function. More than 100 RNA modification proteins (RMPs) have been identified to drive the dynamics of RNA modifications; yet how genetic variation in human RMP genes contributes to the risks of neurological disorders has not been systematically examined. Here we have curated 123 RMPs corresponding to 31 RNA modifications on...

7
First-in-human low-intensity focused ultrasound targeting striatal circuits in schizophrenia: feasibility, safety, and effects on hallucinations and striatal-temporal functional connectivity
2026-01-13 psychiatry and clinical psychology 10.64898/2026.01.10.26343837
Top 0.2% (7.7%)
Show abstract

BackgroundAuditory hallucinations are among the most disabling symptoms in individuals with schizophrenia (SZ) and are linked to aberrant signaling within deep-striatal circuits, such as the nucleus accumbens (NAc) and caudate head (CH). However, causal tests of striatal involvement have been limited by the inaccessibility of these structures using noninvasive neuromodulatory techniques. Low-intensity focused ultrasound (LIFU) provides millimeter-scale precision capable of modulating deep-brain ...

8
IL-17A, IFN-γ, and MIP-3α Plasma Profiles Predict Clinical Stage Transition in First-Episode Psychosis
2026-02-22 psychiatry and clinical psychology 10.64898/2026.02.17.26346145
Top 0.2% (7.6%)
Show abstract

BackgroundEarly detection of individuals at risk for clinical deterioration in first-episode psychosis (FEP) remains a vital challenge in psychiatric care. Emerging evidence indicates that immune dysregulation might play a crucial role in the pathophysiology and progression of psychotic disorders. AimsThis study examined the predictive potential of a plasma cytokine and chemokine panel in anticipating clinical stage transition of FEP patients. MethodUsing multiplex immunoassays, plasma samples...

9
Imaging Blood-Brain Barrier Dysfunction in Schizophrenia Spectrum Disorders: protocol of the longitudinal IMPACT DCE-MRI study
2026-01-11 psychiatry and clinical psychology 10.64898/2026.01.09.26343751
Top 0.2% (7.6%)
Show abstract

Schizophrenia spectrum disorders (SSDs) are clinically and biologically heterogeneous and lack reliable biomarkers for stratification and outcome prediction. Evidence from postmortem, fluid biomarker, and neuroimaging studies suggests that blood-brain barrier (BBB) dysfunction may contribute to pathophysiology in a biologically defined subgroup. However, findings are inconsistent and often based on cross-sectional or indirect measures. The IMPACT study is a longitudinal, multimodal investigatio...

10
Causal Modulation of Brain Body Habituation Dynamics Implicates Salience Network Mechanisms in Anxiety
2026-01-06 psychiatry and clinical psychology 10.64898/2026.01.05.26343461
Top 0.2% (7.6%)
Show abstract

Anxiety is marked by exaggerated vigilance which may be linked to impaired sensory habituation, yet the physiological mechanisms linking anxiety to dysregulated habituation in the brain remain unclear. The brains ability to filter sensory input is characteristic of healthy functioning and disruption of this can lead to over-responsiveness and hypervigilance that may underlie pathological anxiety. Here, we examined how state and trait anxiety relate to acoustic startle reflex habituation across s...

11
Multi-Ancestry GWAS of Neuroticism Identifies Novel Loci and Enhances Fine-Mapping Resolution
2025-12-15 genetic and genomic medicine 10.64898/2025.12.12.25342160
Top 0.2% (7.6%)
Show abstract

Neuroticism is a core personality trait linked to emotional instability and increased risk for anxiety, depression, and schizophrenia. Most genome-wide association studies (GWAS) have focused on European populations, limiting the discovery of ancestry-specific genetic influences. To address this gap, we conducted the most diverse multi-ancestry GWAS meta-analysis of neuroticism to date, analyzing 668,780 individuals across African (AFR), European (EUR), East Asian (EAS), and South Asian (SAS) po...

12
Disentangling the Link Between Bullying Exposure, Psychosis-like Experiences, and Functional Network Connectivity in Adolescence
2026-02-05 psychiatry and clinical psychology 10.64898/2026.02.04.26345538
Top 0.2% (7.5%)
Show abstract

Bullying is an adverse childhood experience affecting up to one-third of the global population and linked to psychosis-like experiences (PLEs), which increase the risk of psychotic disorders. This study aimed to investigate the association between the severity and persistence of bullying and PLEs and the neurobiological pathways from bullying to psychosis-like experiences by assessing multiscale brain functional network connectivity (msFNC). We used data from the ABCD Study, a large, ongoing, mu...

13
Personalization and network specificity of cerebellar TMS in schizophrenia
2025-12-22 psychiatry and clinical psychology 10.64898/2025.12.19.25342404
Top 0.2% (7.5%)
Show abstract

BackgroundCerebellar transcranial magnetic stimulation (TMS) may serve as an adjuvant therapy for psychosis symptoms, most recently we have shown improvements in negative symptoms. Historically, cerebellum TMS has not utilized functional neuroanatomy for targeting, and the precision of TMS to the cerebellum is unclear. A classical view of the cerebellum as solely involved in motor computations has been updated with the discovery of rich non-motor connectivity including the default, dorsal attent...

14
Phenome-wide analysis of genetically imputed neuroimaging phenotypes reveals associations with psychiatric traits in a multi-ancestry cohort
2025-12-17 genetic and genomic medicine 10.64898/2025.12.16.25342202
Top 0.3% (7.4%)
Show abstract

BackgroundUnderstanding how variation in brain structure and function contributes to psychiatric and behavioral phenotypes remains a key challenge. The absence of neuroimaging data in many study samples limits this effort. MethodsWe used genome-wide association study (GWAS) summary statistics from the UK Biobank to impute 301 brain imaging-derived phenotype (IDP) genetic scores (IGS) in the Yale-Penn cohort, which is enriched for substance use disorders (n = 10,275; 52.8% European-like [EUR] an...

15
Neurobehavioral Changes in Fear Generalization in Clinical High Risk for Psychosis
2026-01-16 psychiatry and clinical psychology 10.64898/2026.01.14.26344102
Top 0.3% (7.3%)
Show abstract

Changes in basic associative learning processes have been identified in several psychiatric conditions. However, it remains unknown whether these findings result from ongoing psychopathology or represent an underlying transdiagnostic risk factor for multiple clinical states. In this study, 72 participants with subclinical psychopathology, 23 of whom met criteria for the clinical high-risk for psychosis transdiagnostic risk syndrome (CHR+), completed a fear conditioning and generalization paradig...

16
Parietal Default Mode Network Connectivity is Associated with Tobacco Use in Psychosis
2026-03-03 psychiatry and clinical psychology 10.64898/2026.03.02.26347415
Top 0.3% (7.3%)
Show abstract

Background and HypothesisAbnormal default mode network (DMN) connectivity was observed in both tobacco use and psychotic spectrum disorders, but it remains unknown how psychosis impacts the relationship between connectivity and tobacco use. Interventions targeting the left lateral parietal DMN node (LLPDMN) have modulated DMN connectivity and nicotine craving in psychosis. We aimed to investigate relationships between DMN connectivity, psychotic illness, and tobacco use. Study Design336 partici...

17
The Course of Relapse Following Antipsychotic Discontinuation in Schizophrenia: A Test of the Antipsychotic Withdrawal Syndrome Hypothesis of Relapse
2026-01-22 psychiatry and clinical psychology 10.64898/2026.01.19.26344378
Top 0.3% (7.3%)
Show abstract

BackgroundAntipsychotics are central to relapse prevention in schizophrenia, but longer-term use is associated with adverse effects that often prompt dose reduction or discontinuation. Although relapse risk increases after discontinuation, the nature of relapse remains unclear. Specifically, it is uncertain whether relapse reflects re-emergence of underlying illness or pharmacological withdrawal. MethodsWe analysed longitudinal symptom data (Positive and Negative Syndrome Scale; PANSS) from 417...

18
Evaluating Resting State EEG Biomarkers Across Psychosis Biotypes: Stability and HD-tDCS Modulation
2026-02-25 psychiatry and clinical psychology 10.64898/2026.02.23.26346924
Top 0.3% (7.3%)
Show abstract

ObjectiveWe examined the clinical utility of resting state electroencephalography (rsEEG) by evaluating its temporal stability, discriminant validity for B-SNIP psychosis Biotypes, and suitability as a treatment target for brain stimulation. MethodsWe collected 5 minutes of eyes-open rsEEG from 1401 participants with psychosis and 750 healthy persons. A subset of participants was re-tested after 6 months and 12 months (N=109). In a pilot target engagement study (n=5) we collected rsEEG before a...

19
Association of Brain Structural Measurements and Polygenic Risk Scores with Obsessive-Compulsive Symptoms in Adolescents Diagnosed with Obsessive-Compulsive Disorder, Attention-Deficit/Hyperactivity Disorder, Anxiety, Depression, Autism and Tic Disorders
2025-12-22 genetic and genomic medicine 10.64898/2025.12.17.25342484
Top 0.3% (7.3%)
Show abstract

Obsessive-compulsive symptoms, characterized by intrusive thoughts and repetitive behaviors, are prevalent among youth. These symptoms are known to be moderately heritable and linked to structural brain changes involved in their pathophysiology. This study investigates the connections between structural brain alterations (cortical thickness, surface area and subcortical volume), genetic variation, and childhood obsessive-compulsive symptom scores within 143 samples of healthy control participant...

20
Genetic Signal Augmentation of Childhood-Onset and Treatment-Resistant Major Depression Reveals Distinct Biological Disorders
2026-03-03 psychiatry and clinical psychology 10.64898/2026.03.02.26347449
Top 0.4% (6.6%)
Show abstract

Major depression (MD) is a disorder class that exhibits substantial phenotypic and clinical heterogeneity, yet many large-scale molecular genetic investigations treat MD as a unitary outcome. Here, we applied Genomic Structural Equation Modeling (Genomic SEM) to characterize the genetic variation in two clinically relevant MD subtypes, childhood-onset (child-onset) and treatment-resistant MD, that are independent of the field-standard GWAS of MD in all its forms. In addition, we fit a complement...